Contineum Therapeutics, Inc. Class A Common Stock

CTNMNASDAQ • USD
9.52 USD
↘ 0.34 (3.45%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is currently trading at $9.52. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CTNM appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$9.67
High?$9.93
Low?$9.48
Prev. Close?$9.86
Volume?130.9K
Avg. Volume?1.0M
VWAP?$9.68
Rel. Volume?0.13x
Bid / Ask
Bid?$9.45 × 100
Ask?$10.91 × 100
Spread?$1.46
Midpoint?$10.18
Valuation & Ratios
Market Cap?387.2M
Shares Out?35.4M
Float?28.0M
Float %?85.0%
P/E Ratio?N/A
P/B Ratio?1.58
EPS?-$1.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
Employees
51
Market Cap
387.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-04-05
Address
3565 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 333-5280
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?19.05Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.20%High
Short Interest?3.7M
Days to Cover?4.2
Free Float28.0M
Avg Daily Volume874.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?31.11Strong
Quick Ratio?31.11Strong
Cash Ratio?9.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
85
1.58CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-25.9%WEAK▾
ROA?
S&P
3
-24.7%WEAK▾
Cash Flow & Enterprise
FCF?$-52229000
Enterprise Value?$312.0M
Fundamentals ratios updated end of day